Torres Denice

CIK 00018202787 companiesHAMPTON, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001820278

Recent Transactions

50 trades

Award
Celldex Therapeutics, Inc.$CLDX
Non-Qualified Stock Option (right to buy)
2026-06-25+26,000→ 26,000 total
Award
GLAUKOS Corp$GKOS
Stock Option (Right to Buy)
2026-05-28+2,987→ 2,987 total
Award
GLAUKOS Corp$GKOS
Stock Option (Right to Buy)
2026-05-28+2,987→ 2,987 total
Award
GLAUKOS Corp$GKOS
Common Stock
2026-05-28+1,878→ 24,212 total
Conversion
Seaport Therapeutics, Inc.$SPTX
Series B Preferred Stock
2026-05-04−42,105→ 0 total
Conversion
Seaport Therapeutics, Inc.$SPTX
Common Stock
2026-05-04+13,406→ 13,406 total
Award
Seaport Therapeutics, Inc.$SPTX
Stock Option (Right to Buy)
2026-04-30+12,258→ 12,258 total
Award
GLAUKOS Corp$GKOS
Common Stock
2026-01-02+623→ 22,334 total
Award
Celldex Therapeutics, Inc.$CLDX
Non-Qualified Stock Option (right to buy)
2025-06-05+33,000→ 33,000 total
Award
GLAUKOS Corp$GKOS
Common Stock
2025-05-29+2,108→ 21,711 total
Award
GLAUKOS Corp$GKOS
Stock Option (Right to Buy)
2025-05-29+3,149→ 3,149 total
Disposition from Tender
2seventy bio, Inc.
Common Stock
2025-05-13−19,510→ 0 total
Disposition to Issuer
2seventy bio, Inc.
Stock Options (Right to buy)
2025-05-13−24,100→ 0 total
Disposition to Issuer
2seventy bio, Inc.
Common Stock
2025-05-13−12,050→ 19,510 total
Award
GLAUKOS Corp$GKOS
Common Stock
2025-01-02+461→ 19,603 total
Award
2seventy bio, Inc.
Stock Options (Right to buy)
2024-06-10+24,100→ 24,100 total
Award
2seventy bio, Inc.
Common Stock
2024-06-10+12,050→ 31,560 total
Award
GLAUKOS Corp$GKOS
Stock Option (Right to Buy)
2024-05-30+1,246→ 1,246 total
Award
GLAUKOS Corp$GKOS
Common Stock
2024-05-30+1,716→ 19,142 total
Disposition to Issuer
Karuna Therapeutics, Inc.
Option (right to buy)
2024-03-18$201.99/sh−8,500→ 0 total
Disposition to Issuer
Karuna Therapeutics, Inc.
Option (right to buy)
2024-03-18$92.30/sh−1,904→ 0 total
Disposition to Issuer
Karuna Therapeutics, Inc.
Option (right to buy)
2024-03-18$227.04/sh−5,000→ 0 total
Disposition to Issuer
Karuna Therapeutics, Inc.
Common Stock
2024-03-18$330.00/sh−990→ 0 total
Disposition to Issuer
Karuna Therapeutics, Inc.
Option (right to buy)
2024-03-18$225.74/sh−25,000→ 0 total
Award
GLAUKOS Corp$GKOS
Common Stock
2024-01-02+895→ 17,426 total
Award
Karuna Therapeutics, Inc.
Option (right to buy)
2023-06-20+1,904→ 1,904 total
Award
Karuna Therapeutics, Inc.
Common Stock
2023-06-20+990→ 990 total
Award
2seventy bio, Inc.
Common Stock
2023-06-13+8,400→ 19,510 total
Award
2seventy bio, Inc.
Stock Option (right to buy)
2023-06-13+16,900→ 16,900 total
Award
GLAUKOS Corp$GKOS
Common Stock
2023-06-01+3,230→ 16,531 total
Award
GLAUKOS Corp$GKOS
Common Stock
2023-01-03+1,572→ 13,301 total
Award
Karuna Therapeutics, Inc.
Option (right to buy)
2022-06-15+5,000→ 5,000 total
Award
2seventy bio, Inc.
Stock Option (right to buy)
2022-06-08+16,900→ 16,900 total
Award
2seventy bio, Inc.
Common Stock
2022-06-08+8,200→ 11,110 total
Award
Surface Oncology, Inc.
Stock Option (Right to Buy)
2022-06-08+24,000→ 24,000 total
Award
GLAUKOS Corp$GKOS
Common Stock
2022-06-02+4,364→ 11,729 total
Award
Surface Oncology, Inc.
Stock Option (Right to Buy)
2022-01-03+12,000→ 12,000 total
Award
GLAUKOS Corp$GKOS
Common Stock
2022-01-03+1,455→ 7,365 total
Disposition to Issuer
bluebird bio, Inc.
Stock Option (right to buy)
2021-11-11−4,500→ 4,430 total
Other
bluebird bio, Inc.
Common Stock
2021-11-11+0→ 2,726 total
Other
bluebird bio, Inc.
Common Stock
2021-11-11+1,476→ 2,726 total
Disposition to Issuer
bluebird bio, Inc.
Stock Option (right to buy)
2021-11-11−5,000→ 0 total
Award
2seventy bio, Inc.
Common Stock
2021-11-11+492→ 492 total
Award
2seventy bio, Inc.
Stock Option (right to buy)
2021-11-11+3,219→ 3,219 total
Award
2seventy bio, Inc.
Stock Option (right to buy)
2021-11-11+1,476→ 1,476 total
Award
2seventy bio, Inc.
Common Stock
2021-11-11+2,002→ 2,910 total
Award
Surface Oncology, Inc.
Stock Option (Right to Buy)
2021-08-02+36,000→ 36,000 total
Award
Karuna Therapeutics, Inc.
Option (right to buy)
2021-06-16+8,500→ 8,500 total
Award
bluebird bio, Inc.
Common Stock
2021-06-15+3,109→ 5,859 total
Award
bluebird bio, Inc.
Stock Option (right to buy)
2021-06-15+5,000→ 5,000 total

Companies

Recent Filings

Address

C/O CELLDEX THERAPEUTICS, INC. 53 FRONTAGE ROAD, SUITE 220

HAMPTON, NJ, 08827

View on SEC.gov